This web site is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

Human Parthenogenetic Stem Cells

International Stem Cell Corporation

Drug Names(s): hpSCs, hPNSC (neural), ISC-hpNSC

Description: Parthenogenetic stem cells are derived from parthenogenetically activated human oocytes. Parthenogenetic activation of metaphase II (MII) oocytes with a combination of the activating agents ionomycin and 6-dimethylaminopurine (6-DMAP) block the extrusion of the 2nd polar body, therefore activated oocytes retain all of their genetic material. The HLA genotypes of stem cells derived from these oocytes are heterozygous and genetically matched to the donors.


Human Parthenogenetic Stem Cells News


Additional information available to subscribers only:

  • Targets
  • Routes
  • Catalysts
  • Designations
  • Events

Request a Free Demo Subscriber Login Search for another drug